Christy Oliger
Directeur/Bestuurslid bij KARYOPHARM THERAPEUTICS INC.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Christy Oliger
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
46
| Subsidiary | Biotechnology | 46 |
| Public Company | Pharmaceuticals: Major | 33 | |
| Subsidiary | Pharmaceuticals: Major | 29 | |
| Extinct | Biotechnology | 28 | |
| Public Company | Biotechnology | 22 | |
| Public Company | Biotechnology | 19 | |
| Public Company | Biotechnology | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christy Oliger via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Sales & Marketing Compliance Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Founder Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member President | |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Corporate Officer/Principal | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member President | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member Chairman | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Doctorate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director of Finance/CFO Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Director/Board Member Founder | |
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Vrije Universiteit Amsterdam | College/University | Undergraduate Degree Doctorate Degree | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Verenigd Koninkrijk | 5 |
| Nederland | 5 |
| Denemarken | 3 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 5 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 531 |
| Corporate Officer/Principal | 246 |
| Independent Dir/Board Member | 166 |
| Undergraduate Degree | 74 |
| Director of Finance/CFO | 67 |
Sterkste connecties
| Insiders | |
|---|---|
| James Noble | 39 |
| Kapil Dhingra | 39 |
| Martin Edwards | 38 |
| Jack Nielsen | 38 |
| Otello Stampacchia | 37 |
| Hugo Slootweg | 34 |
| Dieter Weinand | 32 |
| Deepa Pakianathan | 32 |
| Karen Wilson | 31 |
| Maha Katabi | 28 |
| Peter Kiener | 25 |
| Jason Rhodes | 24 |
| Michael Kauffman | 24 |
| Chen Schor | 23 |
| Gaurav Aggarwal | 21 |
- Beurs
- Insiders
- Christy Oliger
- Bedrijfsconnecties
